We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$3.49B
AUM Growth
+$308M
Cap. Flow
-$9.33M
Cap. Flow %
-0.27%
Top 10 Hldgs %
56.89%
Holding
645
New
145
Increased
110
Reduced
156
Closed
135

Top Buys

Rank Stock Value
1
JNPR
Juniper Networks
JNPR
+$162M
2
AXNX
Axonics, Inc. Common Stock
AXNX
+$128M
3
ANSS
Ansys
ANSS
+$119M
4
X
US Steel
X
+$104M
5
CTLT
CATALENT, INC.
CTLT
+$93.3M

Top Sells

Rank Stock Value
1
SPLK
Splunk Inc
SPLK
+$561M
2
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
+$120M
3
IMGN
Immunogen Inc
IMGN
+$56.8M
4
CPRI icon
Capri Holdings
CPRI
+$44.2M
5
PXD
Pioneer Natural Resource Co.
PXD
+$34M

Sector Composition

Rank Sector Weight
1 Energy 34.28%
2 Technology 15.43%
3 Healthcare 14.7%
4 Industrials 8%
5 Materials 6.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXGN icon
251
Axogen
AXGN
$2.38B
$1.11M 0.03%
137,575
– –
PTON icon
252
PUT
Peloton Interactive
PTON
$2.38B
$1.1M 0.03%
725,000
-312,500
-30% -$1.54M
ALCY
253
DELISTED
Alchemy Investments Acquisition Corp 1
ALCY
$1.1M 0.03%
+103,486
New +$1.09M
KPTI icon
254
Karyopharm Therapeutics
KPTI
$44.2M
$1.09M 0.03%
48,155
-5,333
-10% -$93.5K
NXRT
255
NexPoint Residential Trust
NXRT
$637M
$1.08M 0.03%
+33,550
New +$1.04M
HYAC
256
DELISTED
Haymaker Acquisition Corp 4
HYAC
$1.08M 0.03%
103,486
– –
AAT
257
American Assets Trust
AAT
$1.38B
$1.05M 0.03%
+48,100
New +$1.06M
MGM icon
258
MGM Resorts International
MGM
$11.2B
$1.03M 0.03%
21,726
-10,515
-33% -$460K
ROIV icon
259
Roivant Sciences
ROIV
$25.4B
$1.02M 0.03%
97,217
-101,215
-51% -$1.09M
BSX icon
260
Boston Scientific
BSX
$71.4B
$1.01M 0.03%
14,800
-4,985
-25% -$321K
CGEM icon
261
Cullinan Oncology
CGEM
$1.16B
$1.01M 0.03%
59,352
+5,000
+9% +$77.3K
EQIX icon
262
Equinix
EQIX
$104B
$1.01M 0.03%
1,224
-2,269
-65% -$1.91M
RIGL icon
263
Rigel Pharmaceuticals
RIGL
$733M
$996K 0.03%
67,275
-22,659
-25% -$305K
AUTL
264
Autolus Therapeutics
AUTL
$532M
$994K 0.03%
155,857
-382,909
-71% -$2.39M
KALV
265
DELISTED
KalVista Pharmaceuticals
KALV
$973K 0.03%
+82,000
New +$1.09M
TTD icon
266
Trade Desk
TTD
$8.31B
$962K 0.03%
11,000
-4,000
-27% -$303K
SHO icon
267
Sunstone Hotel Investors
SHO
$2.1B
$960K 0.03%
+86,150
New +$941K
DYN icon
268
Dyne Therapeutics
DYN
$4.83B
$940K 0.03%
33,125
-24,205
-42% -$547K
SYRS
269
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$936K 0.03%
175,000
+45,000
+35% +$311K
DEI icon
270
Douglas Emmett
DEI
$1.93B
$927K 0.03%
+66,825
New +$915K
INCY icon
271
Incyte
INCY
$24B
$926K 0.03%
16,250
-24,750
-60% -$1.49M
ACRV icon
272
Acrivon Therapeutics
ACRV
$72.3M
$908K 0.03%
126,949
+33,506
+36% +$156K
MCHP icon
273
Microchip Technology
MCHP
$40.4B
$897K 0.03%
+10,000
New +$862K
CNTB
274
Connect Biopharma Holdings
CNTB
$138M
$889K 0.03%
510,701
-50,490
-9% -$61.4K
TRIS
275
DELISTED
Tristar Acquisition I Corp.
TRIS
$884K 0.03%
80,656
– –
9 10
11
12 13

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q1 2024 Portfolio in Review

As of Q1 2024, UBS O'Connor held 645 positions worth $3.49B, up 9.7% from $3.18B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

UBS O'Connor's Q1 2024 filing shows 145 new, 110 increased, 156 reduced and 135 closed positions. Its largest new stake was Juniper Networks: 4,428,704 shares worth $164M. The largest sale was Splunk Inc, an estimated $561M.

By sector, the portfolio is most concentrated in Energy at 34% of assets, up from 30% a quarter earlier, followed by Technology and Healthcare.

  • UBS O'Connor's largest Q1 2024 buy was Juniper Networks: 4,428,704 shares worth $164M.
  • UBS O'Connor added most to Axonics, Inc. Common Stock in Q1 2024, an estimated $128M increase.
  • UBS O'Connor's biggest Q1 2024 reduction was Pioneer Natural Resource Co., cutting an estimated $34M.
  • UBS O'Connor fully exited Splunk Inc in Q1 2024, selling an estimated $561M.
  • UBS O'Connor's ten largest holdings make up 57% of its $3.49B portfolio in Q1 2024.
  • UBS O'Connor opened 145 new positions and closed 135 in Q1 2024.
  • UBS O'Connor's portfolio value rose 9.7% quarter-over-quarter to $3.49B.

Based on UBS O'Connor's 13F filing for Q1 2024, filed 15 May 2024.